Nelson, Aurelie
Bheemraj, Kalisha
Dean, Sarah Schoetz
de Voux, Alex
Hlatshwayo, Lerato
Mvududu, Rufaro
Berkowitz, Natacha
Neumuller, Caroline
Jacobs, Shahida
Fourie, Stephanie
Coates, Thomas
Gail-Bekker, Linda
Myer, Landon
Davey, Dvora Joseph
Funding for this research was provided by:
National Institutes of Mental Health (R01MH116771, R01MH116771, R01MH116771, R01MH116771, R01MH116771, R01MH116771, R01MH116771, R01MH116771)
Fogarty International (K01TW011187, K01TW011187, K01TW011187, K01TW011187, K01TW011187, K01TW011187, K01TW011187, K01TW011187, K01TW011187)
City of Cape Town
Western Cape Province
Desmond Tutu Foundation
Article History
Received: 22 November 2023
Accepted: 2 August 2024
First Online: 26 August 2024
Declarations
:
: Ethical review and approval were provided by UCT Human Research Ethics Committee (UCT HREC) (ref. 032/22). The intervention was approved by CCT Research Board (ref. 9520) and by the Western Cape Province Health Research (ref. WC_202205_018). All providers provided written consent to be part of the study. Passive consent was obtained at the clinics from women attending antenatal care and well-baby or immunisation visits with posters explaining the ongoing aggregate data collection about PrEP use and giving the option to women to opt out or withdraw consent at any time. The passive consent process was approved by UCT HREC.
: Not applicable
: LGB: Honoraria from MSD (PTY) LTD (New Jersey, USA), Gilead (California, USA, ViiV Healthcare (London, UK)